These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12392586)

  • 1. Repeatability of local forearm vasoconstriction to endothelin-1 measured by venous occlusion plethysmography.
    Strachan FE; Newby DE; Sciberras DG; McCrea JB; Goldberg MR; Webb DJ
    Br J Clin Pharmacol; 2002 Oct; 54(4):386-94. PubMed ID: 12392586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
    Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
    Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intra-arterial endothelin on resting blood flow and sympathetically mediated vasoconstriction in the forearm of man.
    Cockcroft JR; Clarke JG; Webb DJ
    Br J Clin Pharmacol; 1991 May; 31(5):521-4. PubMed ID: 1888618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged pharmacodynamic effects of S-0139, an intravenously administered endothelin A (ET) antagonist, in the human forearm blood flow model.
    Lunnon MW; Wallace SM; Palmer JE; Francis-Lang A; Laurijssens BE; Mistry P; Albala B; Nagafuji T; Wilkinson IB; Maltby K
    Br J Clin Pharmacol; 2010 Mar; 69(3):252-61. PubMed ID: 20233196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
    Wimalasundera RC; McG Thom SA; Regan L; Hughes AD
    Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction.
    Ferro CJ; Haynes WG; Johnston NR; Lomax CC; Newby DE; Webb DJ
    Br J Clin Pharmacol; 1997 Oct; 44(4):377-83. PubMed ID: 9354313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography.
    Vanmolkot FH; de Hoon JN
    Br J Clin Pharmacol; 2005 Apr; 59(4):387-97. PubMed ID: 15801933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
    Ferro CJ; Strachan FE; Shepherd E; Haynes WG; Webb DJ
    Clin Pharmacol Ther; 2000 Jul; 68(1):67-74. PubMed ID: 10945317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoconstriction to endothelin-1 is blunted in non-insulin-dependent diabetes: a dose-response study.
    McAuley DF; McGurk C; Nugent AG; Hanratty C; Hayes JR; Johnston GD
    J Cardiovasc Pharmacol; 2000 Aug; 36(2):203-8. PubMed ID: 10942162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability.
    Newby DE; Sciberras DG; Mendel CM; Gertz BJ; Boon NA; Webb DJ
    Br J Clin Pharmacol; 1997 May; 43(5):493-9. PubMed ID: 9159564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension.
    Ferro CJ; Haynes WG; Hand MF; Webb DJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():53S-58S. PubMed ID: 12193054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilator effects of the endothelin ET receptor selective antagonist BMS-193884 in healthy men.
    Dhaun N; Strachan FE; Newby DE; Johnston NR; Ford NF; Hammett JL; Palmisano M; Webb DJ
    Br J Clin Pharmacol; 2005 Dec; 60(6):611-22. PubMed ID: 16305585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urotensin II evokes potent vasoconstriction in humans in vivo.
    Böhm F; Pernow J
    Br J Pharmacol; 2002 Jan; 135(1):25-7. PubMed ID: 11786476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How reproducible is bilateral forearm plethysmography?
    Petrie JR; Ueda S; Morris AD; Murray LS; Elliott HL; Connell JM
    Br J Clin Pharmacol; 1998 Feb; 45(2):131-9. PubMed ID: 9491825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired vasoconstriction to endothelin 1 in patients with NIDDM.
    Nugent AG; McGurk C; Hayes JR; Johnston GD
    Diabetes; 1996 Jan; 45(1):105-7. PubMed ID: 8522053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial vasopressin in the human forearm: pharmacodynamics and the role of nitric oxide.
    Affolter JT; McKee SP; Helmy A; Jones CR; Newby DE; Webb DJ
    Clin Pharmacol Ther; 2003 Jul; 74(1):9-16. PubMed ID: 12844130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local forearm vasoconstriction to endothelin-1 measured by venous occlusion plethysmography in vivo.
    Strachan FE; Webb DJ
    Methods Mol Biol; 2002; 206():229-37. PubMed ID: 12152231
    [No Abstract]   [Full Text] [Related]  

  • 18. Contribution of endogenous generation of endothelin-1 to basal vascular tone.
    Haynes WG; Webb DJ
    Lancet; 1994 Sep; 344(8926):852-4. PubMed ID: 7916401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the non peptide angiotensin II antagonist, GR117289C on the vasoconstrictor actions of angiotensin II in the human forearm.
    Lyons D; Webster J; Nixon A; Young MM; Smith J; Benjamin N
    Br J Clin Pharmacol; 1997 Mar; 43(3):323-6. PubMed ID: 9088589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced vasoconstrictor response to endothelin-B-receptor stimulation in patients with atherosclerosis.
    Pernow J; Böhm F; Johansson BL; Hedin U; Rydén L
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S418-20. PubMed ID: 11078438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.